Table of Contents
<< Previous Issue | Sep 2004 (Vol: 2004, Issue: 51) | Next Issue >> |
- Section: Business Commentaries
-
Getting the Deal Value Right!
- Section: Company Profile
-
Toyama Chemical Co. Ltd.
- Section: Deal Trackers
-
Erbitux (cetuximab)
- Section: General
-
Deltanoid’s and Abbott’s Renal Partnership
- Section: Licensing
-
Structural GenomiX Acquires Troxatyl® from Shire
-
Agensys and Genentech in Cancer Antibody Agreement
- Section: Mergers & Acquisitions
-
Mylan to Acquire King for US$4 B
-
Roche Consumer Health Sold to Bayer
- Section: Research & Development
-
Takeda and Lexicon Form Hypertension Collaboration
-
Codexis and Pfizer Collaborate on Pharmaceutical Life Cycle Management